FMC Corporation 10-Q Summary: Period Ended September 30, 2007
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2007, and the nine-month period ended on that date. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The financial statements reflect a two-for-one stock split effective September 13, 2007. The company reported 75,611,338 shares of common stock outstanding as of September 30, 2007.
Key Financial Metrics
| Metric (in Millions) | Three Months Ended 9/30/07 | Nine Months Ended 9/30/07 | Nine Months Ended 9/30/06 |
|---|---|---|---|
| Revenue | $626.6 | $1,958.6 | $1,758.6 |
| Net Income | $37.1 | $91.5 | $119.1 |
| Diluted EPS (Net Income) | $0.48 | $1.18 | $1.50 |
| Operating Cash Flow (Continuing Ops) | N/A | $230.1 | $251.1 |
| Total Debt | $572.1 | $572.1 | $629.7 (Dec 31, 2006) |
| Cash and Equivalents | $115.9 | $115.9 | $165.5 (Dec 31, 2006) |
Segment Performance (Nine Months 2007 vs. 2006):
- Agricultural Products: Revenue increased 15.5% to $660.2M; Operating Profit increased 37.1% to $175.1M.
- Specialty Chemicals: Revenue increased 11.6% to $498.5M; Operating Profit increased 15.2% to $108.6M.
- Industrial Chemicals: Revenue increased 8.0% to $802.6M; Operating Profit decreased 15.6% to $63.7M due to higher energy costs and lower electricity selling prices in Spain.
Material Changes vs. Prior Period
Consolidated revenue increased 11.4% for the nine months ended September 30, 2007, driven by sales growth across all segments. However, Net Income decreased 23.2% to $91.5 million compared to $119.1 million in the prior year period. This decline was primarily due to significant non-recurring charges and discontinued operations losses.
- Restructuring Charges: Total restructuring and other charges were $140.0 million for the nine months of 2007, compared to $67.6 million in 2006. Major items included an $89.7 million charge for the phase-out of the Baltimore, Maryland facility and a $22.5 million legal settlement with Solutia.
- Discontinued Operations: Reported a loss of $19.3 million in 2007 (vs. income of $6.9 million in 2006), driven by environmental charges and legal reserves at former defense sites (Middleport and Modesto).
- Effective Tax Rate: The effective tax rate for the nine months dropped to 19.4% from 30.0% in the prior year, largely due to the mix of domestic income impacted by restructuring charges versus foreign income.
Guidance, Outlook, and Risks
Outlook: Management expects full-year 2007 revenue growth in the mid-teens for Agricultural Products and low-teens for Specialty Chemicals. Industrial Chemicals revenue is expected to grow approximately 10%, though operating profit is projected to be down approximately 5% due to energy costs.
Capital Allocation: The company increased its quarterly dividend to $0.105 per share. A new $250 million share repurchase program was authorized in April 2007; approximately $80 million was spent on repurchases in the first nine months of 2007.
Risks and Contingencies:
- Regulatory: FMC is litigating against the European Commission regarding the non-approval of carbofuran, carbosulfan, and cadusafos. The company anticipates lost sales will not significantly impact 2007 or 2008 earnings.
- Legal: Ongoing antitrust litigation regarding hydrogen peroxide in the U.S. and Europe. A $25 million fine from the European Commission (recorded in 2006) is being appealed, with interest accruing.
- Environmental: Total environmental reserves are $173.3 million. Management estimates reasonably possible contingent losses may exceed accrued amounts by up to $70 million.
Investor Verification Checklist
- Baltimore Facility Phase-out: Verify the timeline and remaining costs associated with the $89.7 million charge for the Baltimore facility closure, with an additional $35-$45 million expected in future quarters.
- Discontinued Operations Reserves: Review the adequacy of the $19.3 million loss recorded for discontinued operations, specifically regarding environmental liabilities at Middleport and Modesto.
- Regulatory Litigation: Monitor the status of the EU litigation regarding carbofuran and carbosulfan, as a final adverse ruling could impact future Agricultural Products revenue.
- Energy Cost Sensitivity: Assess the impact of rising energy costs on the Industrial Chemicals segment, which saw operating profits decline despite revenue growth.
- Debt Covenants: Confirm continued compliance with leverage and interest coverage covenants under the new $600 million Domestic Credit Agreement and the European Credit Agreement.